Endovascular devices and methods

Information

  • Patent Grant
  • 11793978
  • Patent Number
    11,793,978
  • Date Filed
    Friday, December 10, 2021
    2 years ago
  • Date Issued
    Tuesday, October 24, 2023
    a year ago
Abstract
Devices and methods for the treatment of chronic total occlusions are provided. One disclosed embodiment comprises a method of facilitating treatment via a vascular wall defining a vascular lumen containing an occlusion therein. The method includes providing an intravascular device having a distal portion with a lumen extending therein; inserting the device into the vascular lumen; positioning the distal portion in the vascular wall; and directing the distal portion within the vascular wall.
Description
FIELD OF THE INVENTION

The inventions described herein relate to devices and associated methods for the treatment of chronic total occlusions. More particularly, the inventions described herein relate to devices and methods for crossing chronic total occlusions and subsequently performing balloon angioplasty, stenting, atherectomy, or other endovascular methods for opening occluded blood vessels.


BACKGROUND OF THE INVENTION

Due to age, high cholesterol and other contributing factors, a large percentage of the population has arterial atherosclerosis that totally occludes portions of the patient's vasculature and presents significant risks to patient health. For example, in the case of a total occlusion of a coronary artery, the result may be painful angina, loss of cardiac tissue or patient death. In another example, complete occlusion of the femoral and/or popliteal arteries in the leg may result in limb threatening ischemia and limb amputation.


Commonly known endovascular devices and techniques are either inefficient (time consuming procedure), have a high risk of perforating a vessel (poor safety) or fail to cross the occlusion (poor efficacy). Physicians currently have difficulty visualizing the native vessel lumen, cannot accurately direct endovascular devices toward visualized lumen, or fail to advance devices through the lesion. Bypass surgery is often the preferred treatment for patients with chronic total occlusions, but less invasive techniques would be preferred.


SUMMARY OF THE INVENTION

To address this and other unmet needs, the present invention provides, in exemplary non-limiting embodiments, devices and methods for the treatment of chronic total occlusions. The disclosed methods and devices are particularly beneficial in crossing coronary total occlusions but may also be useful in other vessels including peripheral arteries and veins. In exemplary embodiments, total occlusions are crossed using methods and devices intended to provide a physician visualization of the occluded vascular lumen or provide physical protection for the wall of the artery to prevent perforation. In additional embodiments, devices and methods are disclosed that enhance the ability to direct and advance a guide wire within the vessel lumen.


In one embodiment, visualization of the occluded segment may be achieved by placing a subintimal device in the space around the area of the lesion. Subintimal device placement may be achieved with a subintimal device directing catheter. The catheter orients a subintimal device so that it passes along the natural delamination plane between intima and media approximating a helical path. The subintimal device directing catheter may be an inflatable balloon catheter having proximal and distal ends with two wire lumens. One lumen accepts a conventional guide wire while the second lumen accepts the subintimal device. In an alternative embodiment, the wire directing catheter may be a guide catheter with distal geometry that steers the subintimal device with the appropriate orientation to enter the subintimal space and advance in a helical pattern around the lesion. Visualization of the artery may be achieved as the subintimal device encircles the artery with each helical turn. The wire's shape may approximate the inside diameter of the lumen and also may define axial bends or tortuosity in the vessel. The subintimal device may further serve the purpose of providing mechanical protection for the artery from perforation or damage from subsequently used devices. Once the subintimal device is in place around the lesion, a number of conventional techniques may be used to cross the lesion including for example stiff guide wires, lasers, ultrasonic energy, mechanical dissection, and atherectomy. Alternatively, a guide wire support device may be used that has the ability to rotationally engage the lesion through helical corkscrew profile on the outside surface. An additional aspect may be the ability to independently steer or direct a guide wire support catheter within the vessel lumen while maintaining the ability to rotate, engage, and advance the corkscrew catheter shaft.


The subintimal device may have a mechanism that rotationally engages the arterial tissues and helps drive the wire through the subintimal space. This mechanism may allow the physician to torque the wire at its proximal end, engage the subintimal tissues and achieve wire advancement. This aspect of the wire may for example include a raised helical corkscrew protrusion on the outside surface of the wire. An additional aspect of the subintimal device may include an atraumatic tip that aids in the prevention of arterial perforation.





BRIEF DESCRIPTION OF THE DRAWINGS

It is to be understood that both the foregoing summary and the following detailed description are exemplary. Together with the following detailed description, the drawings illustrate exemplary embodiments and serve to explain certain principles. In the drawings,



FIG. 1A shows an illustration of a heart showing a coronary artery that contains a chronic total occlusion and illustrates the position of the detail section shown in FIGS. 1B-D;



FIG. 1B is an illustration showing a magnified view of a chronic total occlusion;



FIG. 1C is a representation of fluoroscopy image of the chronic total occlusion;



FIG. 1D is a representation of a fluoroscopy image with a subintimal device in position around the lesion;



FIG. 2 is a schematic representation of a coronary artery showing the intimal, medial and adventitial layers;



FIGS. 3A-D illustrate atraumatic tip configurations of a subintimal device;



FIG. 4A is a schematic illustration of a subintimal device;



FIGS. 4B and 4D are cross-sectional views of the subintimal device shown in FIG. 4A taken along line A-A;



FIG. 4C shows a subintimal device body embodiment describing a multi layered coil construction;



FIGS. 4E-G show alternative subintimal device body embodiments;



FIGS. 5A-D show embodiments of subintimal devices having various surface features;



FIGS. 6A-C show schematic and sectional views of a subintimal device directing balloon catheter;



FIG. 7 is a sectional view of a totally occluded vessel with a subintimal device directing balloon catheter inflated proximal to the lesion and a subintimal device advanced partially around the lesion; and



FIGS. 8A-C show an embodiment of an advancement device used to advance devices across the lesion within the vessel lumen.





DETAILED DESCRIPTION OF EXEMPLARY EMBODIMENTS

The following detailed description should be read with reference to the drawings in which similar elements in different drawings are numbered the same. The drawings, which are not necessarily to scale, depict illustrative embodiments and are not intended to limit the scope of the invention.


Referring to FIG. 1, a diseased heart 100 including a chronic total occlusion 101 of a coronary artery 102. FIG. 1B shows a magnified view of a chronic total occlusion 101 within coronary artery 102. The figure shows arterial sections both proximal 103 and distal 104 of lesion 101. The proximal segment 103 may be easily accessed using endovascular devices and has adequate blood flow to supply the cardiac muscle. The distal segment 104 is not easily accessed with interventional devices and has significantly reduced blood flow as compared to proximal segment 103. A commonly performed diagnostic procedure called an angiogram infuses a radiopaque fluid into the arterial bloodstream through a percutaneously placed angiography catheter and records two dimensional images of the arterial pathways using a fluoroscope. FIG. 1C shows an example of an angiographic image of a chronic total occlusion. It is common that the angiogram allows a physician to visualize the proximal segment 103 but does not allow visualization of the distal segment.


An aspect of the disclosure enhances arterial visualization by placing a radiopaque device within the subintimal space around the chronic total occlusion. For the purpose of description, not limitation, the term “subintimal device” will henceforth refer to the wire placed within the subintimal space for purposes of visualization, protecting the vessel, or other purpose, while the term “guide wire” will refer to the wire placed within the vascular lumen for purposes of advancing diagnostic and therapeutic devices within the lumen. FIG. 1D is an additional angiographic image example showing proximal arterial segment 103 and subintimal device 105 positioned concentrically around the chronic total occlusion and within the subintimal space. The subintimal device 105 defines the approximate inside diameter of the artery and also defines axial bends or tortuosity in the vessel.



FIG. 2 shows coronary artery 102 with intimal layer 200 (for sake of clarity, the multi layer intima is shown as a single homogenous layer). Concentrically outward of the intima is the medial layer 201 (which also is comprised of more than one layer but is shown as a single layer). The transition between the external most portion of the intima and the internal most portion of the media is referred to as the subintimal space. The outermost layer of the artery is the adventitia 202.


One aspect of the disclosure is the design of the subintimal device. Embodiments of the subintimal device distal tip are described in FIGS. 3A-D where the tip includes an atraumatic element. Examples of atraumatic elements are a ball tip 301, looped tip 302 and directional tip 303. These elements are intended to distribute axial forces over larger areas of tissue and may reduce the chance of vessel perforation. An additional aspect of the directional tip 303 is ability to torsionally direct the tip and control the path of the device through the subintimal space. The ball tip 301 may be formed from a suitable metallic material including but not limited to stainless steel, silver solder, or braze. The ball tip 301 may also be formed from suitable polymeric materials or adhesives including but not limited to polycarbonate, polyethylene or epoxy. The loop tip 302 and directional tip 303 may be created during the manufacturing process (for example by heat setting or mechanical deformation) or the tip may be shaped (for example by mechanical deformation) by the physician.


In an alternative embodiment, FIG. 3D describes a subintimal device where the hollow internal diameter of the body 300 defines a guide wire lumen. The lumen has proximal and distal ends and can accept a guide wire. The guide wire provides an atraumatic element at its distal end and also provides a mechanism for rotationally steering the subintimal device through the subintimal space. The guide wire may be pushed forward by the subintimal device through an element (i.e. bearing surface) at the proximal or distal end of the subintimal device. This element may provide interference in the axial direction while allowing for relative rotation between the subintimal device and guide wire. An example of a bearing surface may be a collar crimped to the distal end of the guide wire with an outside diameter larger in dimension than the guide wire lumen within the subintimal device.


An additional aspect of the subintimal device is the construction of the device body. The flexibility and torquability of the device body can affect the physician's ability to achieve a helical and subintimal path around the lesion. The sectional view shown in FIG. 4B describes a device body made of a multitude of independent coils 401-403 concentrically wound in opposing directions. These coils can diametrically interact (for example internal coil diametrically expands while the external coil diametrically contracts) with an applied torque. This interaction can provide torsional strength while maintaining axial flexibility. The device body may have sections of increased or decreased torsional or axial rigidity. For example, the proximal most portion of the subintimal device may be formed from a solid stainless steel tube and the distal most section may have the aforementioned multiple coil construction. Alternatively, the device core 404 may be hollow or may contain a permanently fixed wire within its internal lumen. A permanently fixed wire may provide an increase in axial or torsional stiffness. A permanently fixed wire may also have a tapering cross section to increase the distal flexibility. The lumen within a hollow subintimal device may also be used for the insertion of a guide wire. Coils 401-403 and core wire 404 may be made of a suitable metallic or polymeric material including but not limited to stainless steel, nickel titanium, platinum or ultra high molecular weight polyethylene.


In an alternative embodiment, a subintimal device body construction is shown in FIG. 4D where a single coil may be positioned over an internal core. The additional embodiment shown in FIG. 4E shows a single open wound coil 405 as the subintimal device body.


In another embodiment, the subintimal device body may be constructed in part or in total of a single layer coil with geometric features along the coil length that allow adjacent coils to engage (for example mechanical engagement similar to the teeth of a gear). FIG. 4F shows coil 406 closely wound such that the multitude of teeth 407 along the coil edges are in contact such that the peaks of one coil falls within the valleys of the adjacent coil. A conventional coil reacts to an applied torsional load by diametrically expanding or contracting, thus forcing the wire surfaces within a turn of the coil to translate with respect to its neighboring turn. The construction of coil 406 resists the translation of wire surfaces within the coil thus resisting the diametric expansion or contraction (coil deformation). An increased resistance to coil deformation increases the torsional resistance of the device body while the coiled construction provides axial flexibility. An exemplary construction may include a metallic tube where the coil pattern 406 and teeth 407 are cut from the tube diameter using a laser beam. FIG. 4G shows subintimal device body 300 that is for example continuous metallic tube with distal laser cut coil segment 406 and proximal solid tube 408. Tube materials include but are not limited to stainless steel and nickel titanium. Alternatively, the coil 406 may be wound from a continuous wire. The wire has a cross section that for example has been mechanically deformed (stamped) to form the teeth and allow coil engagement.


Another aspect of the disclosure is the exterior surface of the subintimal device. FIG. 5A shows an embodiment where the device body 300 has an external corkscrew 500 that has the ability to rotationally engage the arterial tissues and help drive the device through the subintimal space. FIG. 5B describes an embodiment where one or more round corkscrew members 501 are concentrically wound on the outside of the body 300. Alternatively, FIG. 5C describes a multi-layer device body with layers 401-403 where corkscrew member 503h element of larger cross sectional area wound within the external concentric coil 403. Alternative corkscrew embodiments may include triangular, square, or her cross sections that may aid in tissue engagement and subintimal device advancement. In another exemplary embodiment shown in FIG. 5D, a polymer tube with corkscrew profile 502 may be concentrically positioned around device body 300. Withdrawal of a subintimal device that rotationally engages the arterial tissues may be completed by rotating the device in the opposite direction thus driving the device back out of the subintimal space.


An additional aspect of the disclosure may be a device that directs the subintimal device through the intima and into the subintimal space. In one embodiment shown in FIGS. 6A-C, a balloon catheter with distal balloon 600 and proximal balloon inflation lumen 601 may be advanced over a guide wire that traverses guide wire lumen 602. Once in position us proximal of the chronic total occlusion, the balloon may be inflated within the vessel lumen to direct the subintimal device lumen 603 toward the vessel wall at orientation for subintimal device penetration into the intima and through the subintimal space. FIG. 7 shows subintimal balloon catheter 700 positioned and inflated within coronary artery 102. Subintimal device 105 has been advanced through subintimal device lumen 603 and positioned concentrically outside the chronic total occlusion 101, outside the intimal layer 200, and inside the medial layer 201 and may be contained in the subintimal space.


An alternative method for achieving subintimal position may use a guide catheter that has distal geometry that directs the device toward the interior vessel wall with the appropriate orientation. An example may be a guide catheter that has a permanently formed curve at the distal end suitable for device advancement. Alternatively, the catheter may be actively steerable so that the physician can choose an orientation insitu.


An additional aspect of the disclosure is the method and devices used to advance devices across the lesion within the vessel lumen. A number of conventional techniques may be used including stiff guide wires, lasers, ultrasonic energy, mechanical dissection, atherectomy and other techniques known to those skilled in the art. One aspect of the disclosure may be a guide wire support device intended to enhance guide wire stiffness, engage the lesion thus providing axial support, and allow the physician to direct the tip of the guide wire. FIGS. 8A-8C describe a wire support device where external shaft 800 may be comprised of one or more coils intended to provide axial flexibility and torsional rigidity. External helical profile 801 exists on the outside of the external shaft 800 and may provide mechanical engagement with the lesion. FIG. 8B shows a partial sectional view of the wire support device where internal shaft 803 resides concentrically within the external shaft. The internal shaft 803 contains a guide wire lumen capable of accepting conventional guide wires. The internal shaft may also be comprised of one or more coils. FIG. 8C shows a partial enlarged view of the internal shaft 803 where a gap 804 between adjacent coils allow articulation of the shaft upon proximal withdrawal of actuation wire 805. External shaft 800 can freely rotate with respect to internal shaft 803 when the shaft is in the straight and actuated positions.


From the foregoing, it will be apparent to those skilled in the art that the present invention provides, in exemplary non-limiting embodiments, devices and methods for the treatment of chronic total occlusions. Further, those skilled in the art will recognize that the present invention may be manifested in a variety of forms other than the specific embodiments described and contemplated herein. Accordingly, departures in form and detail may be made without departing from the scope and spirit of the present invention as described in the appended claims.

Claims
  • 1. An intravascular device for treating an occlusion of a blood vessel, comprising: an elongate shaft defining a central longitudinal axis;an inflatable balloon secured to the elongate shaft, the inflatable balloon including an expandable portion;a subintimal device disposed within a subintimal device lumen;a guidewire lumen extending coaxially with the central longitudinal axis to a distal opening positioned distal of the expandable portion of the inflatable balloon; anda balloon inflation lumen in fluid communication with the expandable portion of the inflatable balloon;wherein expansion of the expandable portion of the inflatable balloon orients a distal opening of the subintimal device lumen toward an intimal layer of a wall of the blood vessel;wherein the subintimal device lumen directs the subintimal device toward the wall of the blood vessel upon expansion of the expandable portion of the inflatable balloon such that the subintimal device may be advanced out of the distal opening of the subintimal device lumen to penetrate the intimal layer of the wall of the blood vessel.
  • 2. The intravascular device of claim 1, wherein the subintimal device is configured to be advanced distally within a subintimal space of the blood vessel and positioned concentrically around the occlusion.
  • 3. The intravascular device of claim 1, wherein the balloon inflation lumen extends coaxially with the central longitudinal axis.
  • 4. The intravascular device of claim 1, wherein the distal opening of the guidewire lumen is centered on the central longitudinal axis.
  • 5. The intravascular device of claim 1, wherein the intravascular device is configured to be advanced over a guidewire disposed within the guidewire lumen.
  • 6. The intravascular device of claim 1, further including a tubular distal tip defining the distal opening of the guidewire lumen, the tubular distal tip being disposed distal of a distal end of the expandable portion of the inflatable balloon.
  • 7. The intravascular device of claim 6, wherein the tubular distal tip extends to a distalmost end of the intravascular device.
  • 8. The intravascular device of claim 1, wherein the inflatable balloon has a substantially symmetrical outer profile about the central longitudinal axis in an inflated configuration.
  • 9. The intravascular device of claim 1, wherein the subintimal device lumen extends helically around the inflatable balloon.
  • 10. An intravascular device for treating an occlusion of a blood vessel, comprising: an elongate shaft defining a central longitudinal axis;an inflatable balloon secured to the elongate shaft, the inflatable balloon including an expandable portion;a subintimal device disposed within a subintimal device lumen, the subintimal device lumen extending along an exterior surface of the expandable portion of the inflatable balloon;a guidewire lumen extending coaxially with the central longitudinal axis to a distal opening positioned distal of the expandable portion of the inflatable balloon; anda balloon inflation lumen in fluid communication with the expandable portion of the inflatable balloon;wherein expansion of the expandable portion of the inflatable balloon orients a distal opening of the subintimal device lumen toward an intimal layer of a wall of the blood vessel;wherein the subintimal device lumen directs the subintimal device toward the wall of the blood vessel upon expansion of the expandable portion of the inflatable balloon such that the subintimal device may be advanced out of the distal opening of the subintimal device lumen to penetrate the intimal layer of the wall of the blood vessel.
  • 11. The intravascular device of claim 10, wherein the distal opening of the guidewire lumen is located distal of the distal opening of the subintimal device lumen.
  • 12. The intravascular device of claim 10, wherein the distal opening of the guidewire lumen faces distally.
  • 13. The intravascular device of claim 10, wherein the intravascular device is configured to be advanced over a guidewire disposed within the guidewire lumen to a position proximate the occlusion.
  • 14. The intravascular device of claim 10, wherein the subintimal device lumen is disposed externally to the elongate shaft.
  • 15. The intravascular device of claim 10, wherein the balloon inflation lumen surrounds the guidewire lumen.
  • 16. An intravascular device for treating an occlusion of a blood vessel, comprising: an elongate shaft defining a central longitudinal axis;an inflatable balloon secured to the elongate shaft, the inflatable balloon including an expandable portion;a subintimal device disposed within a subintimal device lumen, wherein a distal opening of the subintimal device lumen is positioned intermediate a proximal end of the expandable portion and a distal end of the expandable portion;a guidewire lumen extending coaxially with the central longitudinal axis to a distal opening positioned distal of the distal end of the expandable portion of the inflatable balloon; anda balloon inflation lumen in fluid communication with the expandable portion of the inflatable balloon;wherein expansion of the expandable portion of the inflatable balloon orients a distal opening of the subintimal device lumen toward an intimal layer of a wall of the blood vessel;wherein the subintimal device lumen directs the subintimal device toward the wall of the blood vessel upon expansion of the expandable portion of the inflatable balloon such that the subintimal device may be advanced out of the distal opening of the subintimal device lumen to penetrate the intimal layer of the wall of the blood vessel.
  • 17. The intravascular device of claim 16, wherein the subintimal device lumen extends along an exterior surface of the elongate shaft.
  • 18. The intravascular device of claim 16, wherein the subintimal device lumen extends along an exterior surface of the inflatable balloon.
  • 19. The intravascular device of claim 18, wherein the subintimal device lumen follows a helical path along the exterior surface of the inflatable balloon.
  • 20. The intravascular device of claim 16, wherein the distal opening of the guidewire lumen is centered on the central longitudinal axis.
CROSS REFERENCE TO RELATED APPLICATIONS

This is a continuation application of U.S. application Ser. No. 16/396,171, filed Apr. 26, 2019, which is a continuation of U.S. application Ser. No. 13/037,797, filed Mar. 1, 2011, now U.S. Pat. No. 10,315,010, which is a continuation of U.S. application Ser. No. 11/518,521, filed Sep. 11, 2006, now U.S. Pat. No. 7,918,870, which claims the benefit of U.S. Provisional Application No. 60/716,287, filed Sep. 12, 2005, the contents of which are incorporated herein by reference.

US Referenced Citations (224)
Number Name Date Kind
4020829 Wilson et al. May 1977 A
4233983 Rocco Nov 1980 A
4569347 Frisbie Feb 1986 A
4581017 Sahota Apr 1986 A
4621636 Fogarty Nov 1986 A
4747821 Kensey et al. May 1988 A
4762130 Fogarty et al. Aug 1988 A
4774949 Fogarty Oct 1988 A
4819634 Shiber Apr 1989 A
4878495 Grayzel Nov 1989 A
4976689 Buchbinder et al. Dec 1990 A
4979939 Shiber Dec 1990 A
4990134 Auth Feb 1991 A
5071406 Jang Dec 1991 A
5127917 Niderhauser et al. Jul 1992 A
5193546 Shaknovich Mar 1993 A
5201753 Lampropoulos et al. Apr 1993 A
5263493 Avitall Nov 1993 A
5275610 Eberbach Jan 1994 A
5324263 Kraus et al. Jun 1994 A
5342301 Saab Aug 1994 A
5356418 Shturman Oct 1994 A
5372587 Hammerslag et al. Dec 1994 A
5383856 Bersin Jan 1995 A
5385152 Abele et al. Jan 1995 A
5409453 Lundquist et al. Apr 1995 A
5415637 Khosravi May 1995 A
5464395 Faxon et al. Nov 1995 A
5501667 Verduin, Jr. Mar 1996 A
5505702 Arney Apr 1996 A
5534007 St. Germain et al. Jul 1996 A
5555883 Avitall Sep 1996 A
5565583 Frank et al. Oct 1996 A
5571122 Kelly et al. Nov 1996 A
5571169 Plaia et al. Nov 1996 A
5603720 Kieturakis Feb 1997 A
5643298 Nordgren et al. Jul 1997 A
5645529 Fagan et al. Jul 1997 A
5655548 Nelson et al. Aug 1997 A
5695506 Pike et al. Dec 1997 A
5728133 Kontos Mar 1998 A
5741270 Hansen et al. Apr 1998 A
5741429 Donadio, III et al. Apr 1998 A
5779721 Nash Jul 1998 A
5807241 Heimberger Sep 1998 A
5824071 Nelson et al. Oct 1998 A
5830222 Makower Nov 1998 A
5830224 Cohn et al. Nov 1998 A
5843050 Jones et al. Dec 1998 A
5910133 Gould Jun 1999 A
5916194 Jacobsen et al. Jun 1999 A
5935108 Katoh et al. Aug 1999 A
5944686 Patterson et al. Aug 1999 A
5954713 Newman et al. Sep 1999 A
5957900 Ouchi Sep 1999 A
5968064 Selmon et al. Oct 1999 A
5989276 Houser et al. Nov 1999 A
6010449 Selmon et al. Jan 2000 A
6013055 Bampos et al. Jan 2000 A
6015405 Schwartz et al. Jan 2000 A
6022343 Johnson et al. Feb 2000 A
6036707 Spaulding Mar 2000 A
6036717 Mers Kelly et al. Mar 2000 A
6059750 Fogarty et al. May 2000 A
6068638 Makower May 2000 A
6071281 Burnside et al. Jun 2000 A
6071292 Makower et al. Jun 2000 A
6081738 Hinohara et al. Jun 2000 A
6099542 Cohn et al. Aug 2000 A
6117064 Apple et al. Sep 2000 A
6120516 Selmon et al. Sep 2000 A
6126649 VanTassel et al. Oct 2000 A
6155264 Ressemann et al. Dec 2000 A
6157852 Selmon et al. Dec 2000 A
6159225 Makower Dec 2000 A
6183432 Milo Feb 2001 B1
6186972 Nelson et al. Feb 2001 B1
6190353 Makower et al. Feb 2001 B1
6203559 Davis et al. Mar 2001 B1
6217527 Selmon et al. Apr 2001 B1
6217549 Selmon et al. Apr 2001 B1
6221049 Selmon et al. Apr 2001 B1
6231546 Milo et al. May 2001 B1
6231587 Makower May 2001 B1
6235000 Milo et al. May 2001 B1
6241667 Vetter et al. Jun 2001 B1
6246914 de la Rama et al. Jun 2001 B1
6254588 Jones et al. Jul 2001 B1
6254598 Edwards Jul 2001 B1
6258052 Milo Jul 2001 B1
6266550 Selmon et al. Jul 2001 B1
6277133 Kanesaka Aug 2001 B1
6283940 Mulholland Sep 2001 B1
6283951 Flaherty et al. Sep 2001 B1
6283983 Makower et al. Sep 2001 B1
6287317 Makower et al. Sep 2001 B1
6302875 Makower et al. Oct 2001 B1
6330884 Kim Dec 2001 B1
6337142 Harder et al. Jan 2002 B2
6358244 Newman et al. Mar 2002 B1
6375615 Flahery et al. Apr 2002 B1
6379319 Garibotto et al. Apr 2002 B1
6387119 Wolf et al. May 2002 B2
6398798 Selmon et al. Jun 2002 B2
6416523 Lafontaine Jul 2002 B1
6428552 Sparks Aug 2002 B1
6432127 Kim et al. Aug 2002 B1
6447539 Nelson et al. Sep 2002 B1
6475226 Belef et al. Nov 2002 B1
6485458 Takahashi Nov 2002 B1
6491660 Guo et al. Dec 2002 B2
6491707 Makower et al. Dec 2002 B2
6506178 Schubart et al. Jan 2003 B1
6508824 Flaherty et al. Jan 2003 B1
6508825 Selmon et al. Jan 2003 B1
6511458 Milo et al. Jan 2003 B2
6514217 Selmon et al. Feb 2003 B1
6544230 Flaherty et al. Apr 2003 B1
6561998 Roth et al. May 2003 B1
6565583 Deaton et al. May 2003 B1
6569143 Alchas et al. May 2003 B2
6569145 Scmulewitz et al. May 2003 B1
6569150 Teague et al. May 2003 B2
6579311 Makower Jun 2003 B1
6589164 Flaherty Jul 2003 B1
6599304 Selmon et al. Jul 2003 B1
6602241 Makower et al. Aug 2003 B2
6613081 Kim et al. Sep 2003 B2
6616675 Evard et al. Sep 2003 B1
6623448 Slater Sep 2003 B2
6638247 Selmon et al. Oct 2003 B1
6638293 Makower et al. Oct 2003 B1
6655386 Makower et al. Dec 2003 B1
6656195 Peters et al. Dec 2003 B2
6660024 Flaherty et al. Dec 2003 B1
6669709 Cohn et al. Dec 2003 B1
6685648 Flaherty et al. Feb 2004 B2
6685716 Flaherty et al. Feb 2004 B1
6694983 Wolf et al. Feb 2004 B2
6695830 Vigil et al. Feb 2004 B2
6709444 Makower Mar 2004 B1
6719725 Milo et al. Apr 2004 B2
6726677 Flaherty et al. Apr 2004 B1
6746426 Flaherty et al. Jun 2004 B1
6746462 Selmon et al. Jun 2004 B1
6746464 Makower Jun 2004 B1
6786884 DeCant, Jr. et al. Sep 2004 B1
6800085 Selmon et al. Oct 2004 B2
6824550 Noriega et al. Nov 2004 B1
6830577 Nash et al. Dec 2004 B2
6837868 Fajnsztajn Jan 2005 B1
6860892 Tanaka et al. Mar 2005 B1
6863684 Kim et al. Mar 2005 B2
6866676 Kieturakis et al. Mar 2005 B2
6884225 Kato et al. Apr 2005 B2
6905505 Nash et al. Jun 2005 B2
6929009 Makower et al. Aug 2005 B2
6936056 Nash et al. Aug 2005 B2
6942641 Seddon Sep 2005 B2
6949125 Robertson Sep 2005 B2
6991617 Hektner et al. Jan 2006 B2
7004173 Sparks et al. Feb 2006 B2
7056325 Makower et al. Jun 2006 B1
7059330 Makower Jun 2006 B1
7083588 Shmulewitz et al. Aug 2006 B1
7094230 Flaherty et al. Aug 2006 B2
7105031 Letort Sep 2006 B2
7134438 Makeower et al. Nov 2006 B2
7137990 Hebert et al. Nov 2006 B2
7159592 Makower et al. Jan 2007 B1
7179270 Makower Feb 2007 B2
7191015 Lamson et al. Mar 2007 B2
7229421 Jen et al. Jun 2007 B2
7316655 Garibotto et al. Jan 2008 B2
7377910 Katoh et al. May 2008 B2
7413556 Zhang Aug 2008 B2
7465286 Patterson Dec 2008 B2
20010000041 Selmon et al. Mar 2001 A1
20010056273 C. Dec 2001 A1
20020029052 Evans et al. Mar 2002 A1
20020052637 Houser et al. May 2002 A1
20020103459 Sparks et al. Aug 2002 A1
20030028200 Berg et al. Feb 2003 A1
20030040737 Merril et al. Feb 2003 A1
20030109809 Jen et al. Jun 2003 A1
20030120195 Milo et al. Jun 2003 A1
20030167038 Yozu et al. Sep 2003 A1
20030236542 Makower Dec 2003 A1
20040015193 Lamson et al. Jan 2004 A1
20040059280 Makower et al. Mar 2004 A1
20040102719 Keith et al. May 2004 A1
20040133225 Makower Jul 2004 A1
20040158143 Flaherty et al. Aug 2004 A1
20040167554 Simpson et al. Aug 2004 A1
20040230156 Schreck et al. Nov 2004 A1
20040249277 Kato et al. Dec 2004 A1
20040249338 DeCant, Jr. et al. Dec 2004 A1
20050038467 Hebert et al. Feb 2005 A1
20050049574 Petrick et al. Mar 2005 A1
20050171478 Selmon et al. Aug 2005 A1
20050177105 Shalev Aug 2005 A1
20050216044 Hong Sep 2005 A1
20050261663 Patterson et al. Nov 2005 A1
20060094930 Sparks et al. May 2006 A1
20060135984 Kramer et al. Jun 2006 A1
20060229646 Sparks Oct 2006 A1
20060271078 Modesitt Nov 2006 A1
20070083220 Shamay Apr 2007 A1
20070088230 Terashi et al. Apr 2007 A1
20070093779 Kugler et al. Apr 2007 A1
20070093780 Kugler et al. Apr 2007 A1
20070093781 Kugler et al. Apr 2007 A1
20070093782 Kugler et al. Apr 2007 A1
20070265596 Jen et al. Nov 2007 A1
20080103443 Kabrick et al. May 2008 A1
20080228171 Kugler et al. Sep 2008 A1
20080243065 Rottenberg et al. Oct 2008 A1
20080243067 Rottenberg et al. Oct 2008 A1
20090088685 Kugler et al. Apr 2009 A1
20090124899 Jacobs et al. May 2009 A1
20090209910 Kugler et al. Aug 2009 A1
20090270890 Robinson et al. Oct 2009 A1
20100063534 Kugler et al. Mar 2010 A1
20100069945 Olson et al. Mar 2010 A1
Foreign Referenced Citations (8)
Number Date Country
0178822 Oct 2001 WO
2007033052 Mar 2007 WO
2008063621 May 2008 WO
2009054943 Apr 2009 WO
2009100129 Aug 2009 WO
2009134346 Nov 2009 WO
2010019241 Feb 2010 WO
2010044816 Apr 2010 WO
Non-Patent Literature Citations (8)
Entry
Bolia, Amman, “Subintimal Angioplasty: Which Cases to Choose, How to Avoid Pitfalls and Technical Tips.” Combined Session: Vascular Surgery and Interventional Radiology, pp. III 8.1-8.3.
Columbo, Antonio et al; “Treating Chronic Total Occlusions Using Subintimal Tracking and Reentry: The Star Technique.” Catheterization and Cardiovascular Interventions, vol. 64: pp. 407-411 (2005).
International Search Report in PCT/US06/35244 dated Mar. 24, 2008.
Written Opinion of International Searching Authority in PCT/US06/35244 dated Mar. 24, 2008.
International Preliminary Report on Patentability in PCT/US06/35244 dated Mar. 17, 2009.
Office Action for U.S. Appl. No. 11/518,428 dated Jul. 1, 2010. (10 pages).
Office Action for U.S. Appl. No. 11/518,428 dated Jan. 28, 2010. (15 pages).
Office Action for U.S. Appl. No. 11/518,428 dated May 29, 2009 (12 pages).
Related Publications (1)
Number Date Country
20220096803 A1 Mar 2022 US
Provisional Applications (1)
Number Date Country
60716287 Sep 2005 US
Continuations (3)
Number Date Country
Parent 16396171 Apr 2019 US
Child 17547442 US
Parent 13037797 Mar 2011 US
Child 16396171 US
Parent 11518521 Sep 2006 US
Child 13037797 US